FDA Participates in TPE24 to Promote Regulations and Policies
The largest tobacco exhibition in North America, TPE24, officially opened in Las Vegas on January 31st, Pacific Standard Time. The participation of the US e-cigarette regulatory agency, FDA, in this exhibition has sparked widespread attention and discussions within the e-cigarette industry. Industry insiders have been speculating on the motive behind FDA's participation.
On the first day of the event, 2FIRSTS obtained information about the purpose of FDA's participation. It is understood that FDA's main objective of participating in the exhibition is to disseminate regulatory knowledge to e-cigarette companies, promote key policies related to FDA's regulation of e-cigarettes, and guide e-cigarette companies towards compliant sales practices. Additionally, they are providing free age verification devices to support e-cigarette companies in fulfilling their social responsibilities effectively.
In addition, 2FIRSTS also conducted interviews with FDA on-site personnel to discuss their future adjustment plans for PMTA. This content will be shared in detail during a live broadcast at the TPE exhibition and American market deep sharing session, held by 2FIRSTS on February 6. In this live event, 2FIRSTS Global Executive Editor Hou Yuhan and the US team will share the latest exhibition findings and delve into US product trends, policy directions, and more. For more information and registration details, please scan the QR code below to contact 2FIRSTS staff.
After the end of the exhibition, 2FIRSTS will be hosting a deep sharing event on TPE and the American market on February 6th. During this event, 2FIRSTS' Global Executive Editor-in-Chief, Yuna Hou, and the American team will share the latest discoveries from the exhibition and delve into topics such as product trends and policy direction in the United States. For more information and registration, please scan the QR code below to contact 2FIRSTS staff members.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
